Evidence map›Paper›PMID 36764690›Full record

ArticleBMJ open gastroenterology2023

BSG 2024 IBD guidelines protocol (standard operating procedures).

Ana-Maria Darie, Vasiliki Sinopoulou, Verma Ajay, Klaartje Bel Kok, Kamal V Patel, Jimmy Limdi, Naila Arebi, Philip Smith, Shahida Din, Said Din and 8 more

Abstract readClinical Trial Protocol
In one paragraph

Article in BMJ open gastroenterology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Guideline
  6. Guideline
  7. Pooled it
  8. Pooled it
  9. Updated review of Janus kinase inhibitors for the management of inflammatory bowel disease.World journal of gastrointestinal pharmacology and therapeutics · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Ana-Maria Darie *Gastroenterology, Nottingham University Hospitals NHS Trust, Nottingham, UK ana-maria.darie@nuh.nhs.uk.ORCID 0000-0001-7896-5134
Vasiliki Sinopoulou *School of Medicine, University of Central Lancashire, Preston, UK.
Verma AjayDigestive Disease, Kettering General Hospital NHS Foundation Trust, Kettering, UK.
Klaartje Bel KokDepartment of Gastroenterology, Barts Health NHS Trust, London, UK.
Kamal V PatelDepartment of Gastroenterology, St George's University Hospitals NHS Foundation Trust, London, UK.ORCID 0000-0003-2611-4260
Jimmy LimdiGastroenterology, Pennine Acute Hospitals NHS Trust, Manchester, UK.
Naila ArebiDepartment of Inflammatory Bowel Disease, St Mark's Hospital, Imperial College London, London, UK.
Philip SmithGastroenterology, University Hospitals NHS Foundation Trust, Liverpool, UK.
Shahida DinGastroenterology, NHS Lothian Edinburgh, Western General Hospital, Clydebank, UK.ORCID 0000-0003-2855-3400
Said DinGastroenterology, Derby Teaching Hospitals, NHS Foundation Trust, Derby, UK.
Matthew ShaleGastroenterology, Queen's Medical Centre Nottingham University Hospital NHS Trust, Nottingham, UK.
Sreedhar SubramanianGastroenterology, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK.
Polychronis PavlidisGastroenterology, School of Immunology and Microbial Sciences, King's College London, London, UK.
Rachel CooneyDepartment of Gastroenterology, University Hospitals Birmingham NHS Trust, Birmingham, UK.ORCID 0000-0003-3710-157X
Dennis McGonagleDepartment of Rheumatology, Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
Newton A C S WongDepartment of Cellular Pathology, Southmead Hospital, Bristol, UK.
Gordon W Moran *Gastroenterology, NIHR Nottingham Biomedical Research Centre at Nottingham University Hospitals, Nottingham, UK.
Morris Gordon *School of Medicine, University of Central Lancashire, Preston, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn the past 5 years, there have been several advances in the management of inflammatory bowel disease (IBD). We aim for a new guideline to update the most recent guideline published in 2019. We present the prospective operating procedure and technical summary protocol in the manuscript.

methods'Grading of Recommendations Assessment, Development and Evaluation' (GRADE) will be followed in the development of the guideline, approach as laid out in the GRADE handbook, supported by the WHO. The guideline development group is formed by a variety of disciplines, across both primary and secondary care that took part in an online Delphi process and split into key areas. A final consensus list of thematic questions within a 'patient, intervention, comparison, outcome' format has been produced and agreed in the final phase of the Delphi process.There will be a detailed technical evidence review with source data including systematic reviews appraised with AMSATAR 2 tool (Assessment of multiple systematic reviews), randomised controlled trial data that will be judged for risk of bias with the Cochrane tool and observational studies for safety concerns assessed through the Robins-I tool. Based on the available evidence, some of the recommendations will be based on GRADE while others will be best practice statements.A full Delphi process will be used to make recommendations using online response systems.This set of procedures has been approved by the Clinical Services and Standards Committee, the British Society of Gastroenterology executive board and aligned with IBD UK standards.

Indexed as

Inflammatory Bowel DiseasesDelivery of Health CareHumansProspective StudiesRandomized Controlled Trials as TopicHEALTH SERVICE RESEARCHIBD BASIC RESEARCHIBD CLINICALINFLAMMATORY BOWEL DISEASESURGERY FOR IBD

Identifiers

PMID36764690
PMCPMC9923295

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.